Amgen Stock Drops 2.25% After Downgrade by HSBC
Amgen stock closed at $382.47 on Nasdaq on September 10, 2026, down 2.25% from its prior close due to fresh pressure.
The shares traded between $381.51 and $391.67 during the session, leaving them well below their 52-week high of around $447 and closer to the $269.77 low.
HSBC downgraded Amgen from Buy to Hold on September 10, 2026, and trimmed its price target from $445 to $425, contributing to the cautious tone around the stock.